| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |